Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
about
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesThe Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in CancerCancer Stem Cell Hierarchy in Glioblastoma MultiformeHow, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activityLung cancer-initiating cells: a novel target for cancer therapyThe role of EMMPRIN in T cell biology and immunological diseasesHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symportersModulation of CD44 Activity by A6-PeptideIn vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147CD44v6 dependence of premetastatic niche preparation by exosomesInduction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cellsInhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literatureUpregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction.The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.ABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells.CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray studyDirect activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosisCancer stem cells and chemoresistance: The smartest survives the raidEmmprin and KSHV: new partners in viral cancer pathogenesis.Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness.Interaction of stellate cells with pancreatic carcinoma cellsEvidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications.IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironmentCD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cellsHyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.Cancer stem cell epigenetics and chemoresistance.Redox regulation in stem-like cancer cells by CD44 variant isoforms.
P2860
Q21562142-A35A9AA7-3BF8-454A-ABCA-48504A317750Q26747319-8EDFD9FD-3B37-40AC-A439-369324564222Q26752312-42E46C87-D9A4-45FA-B9FC-E6B389CE9BB1Q26775999-F1FCC2E5-E2DF-43FA-9D28-5671A9B86021Q26824222-0D3F0DAC-0432-4F92-8C57-B6C9866E1D64Q26998829-F9AE537D-4450-4973-AE8E-FDE40434B468Q28081811-FD42872E-7A55-4EA1-8198-9AC4D2E9565CQ28085166-F90F63D2-2162-4E93-BCB2-B339C5A1401AQ28482047-196756D2-E7BE-44B8-BB50-D6400BA8A3F0Q28568064-5673C6AE-387E-44FD-8261-F6DE45E5D4DDQ30357883-0AB05C37-28AD-4765-8DD2-4DF2008EE035Q30418735-75BB903A-84F0-4EF3-B2D5-B5ECD16A6230Q30431290-6A80AE87-67AA-4CE8-9DD6-B0072069CC35Q30454570-934D114D-76F2-4274-A212-FC66ACD24D7BQ30454572-730BA8BD-B189-43D6-AA3F-A0216089C0B9Q30478184-5FE30C98-B2D3-4442-8527-010A0130E5C1Q33556551-9DDE6576-5D39-4511-A042-048148FB2846Q33824543-7350C542-426E-4672-BA39-3F46C1C7997EQ34003991-743E42B9-2CF5-4DEB-86EE-214C511C170DQ34208986-675FFBA7-8EB7-4228-9393-44AE49CB9D6BQ34309819-62213C13-3DA1-4705-8DDF-BD44801E00FAQ34486547-C9CC9465-05EA-48BC-AE8D-07342BE6C37FQ34733240-A545468A-BEED-4E02-8A61-304C4BAF736CQ34755789-478DCF3F-CFE3-44CE-AA05-8E6A5B1D4C4CQ34999699-1FDA3896-639E-49B9-94C4-374A5095889DQ35017209-D437C63C-974E-4FAF-AA60-3D2487CFBE7DQ35169679-F337F8F2-4ED8-4CBB-9E30-73F95D1A98E6Q35417696-647BB4B2-9746-4814-9B94-62128885B246Q35453802-84936EEE-DC97-455B-8357-09983EF21D22Q36175816-1B644A76-487F-44B8-B530-D2E5445EA356Q36730432-7914877A-D814-4F14-A3E7-7584ED7B42A9Q37057685-093AB31B-7EEF-40BD-AC0F-B15FDCF3949BQ37091959-727D3B3D-2141-427E-A1A6-734BE8853B21Q37334274-BE59F59B-1100-45C1-8CA4-2E4518BC2F2FQ37417591-6A8FC413-FEB8-4D92-9068-85A92D60A691Q37516299-0F4D18B2-2225-43BA-A883-01FA8B4FE0C8Q37628926-7CEFBF52-B5FE-4967-A1BC-177F0A5A4C3CQ37832163-8887EB42-B014-421A-9F4D-550C06F25313Q37961977-7428D479-6C22-4981-AE00-C59CFB673568Q38075424-9463FC12-EE37-4E43-AB3E-209013416D1A
P2860
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
@en
type
label
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
@en
prefLabel
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
@en
P2860
P1476
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
@en
P2093
Bryan P Toole
Mark G Slomiany
P2860
P304
P356
10.1016/J.DRUP.2008.04.002
P577
2008-05-19T00:00:00Z